22
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Interleukin-1 Receptor Antagonists and Other Markers in Colorectal Cancer Patients

, &
Pages 577-581 | Received 02 Dec 1996, Accepted 03 Mar 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Razelle Kurzrock, Tamas Hickish, Lucjan Wyrwicz, Mark Saunders, Qian Wu, Michael Stecher, Prasant Mohanty, Charles A. Dinarello & John Simard. (2019) Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer. OncoImmunology 8:3.
Read now
Maryse Dagenais, Jeremy Dupaul-Chicoine, Todd Douglas, Claudia Champagne, Alexandre Morizot & Maya Saleh. (2017) The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis. OncoImmunology 6:3.
Read now

Articles from other publishers (12)

Shyng-Shiou F. Yuan, Yun-Ming Wang, Leong-Perng Chan, Amos C. Hung, Hieu D. H. Nguyen, Yuk-Kwan Chen, Stephen Chu‐Sung Hu, Steven Lo & Yen-Yun Wang. (2023) IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway. Journal of Translational Medicine 21:1.
Crossref
Lisa Schneider, Junnan Liu, Cheng Zhang, Anca Azoitei, Sabine Meessen, Xi Zheng, Catharina Cremer, Christian Gorzelanny, Sybille Kempe-Gonzales, Cornelia Brunner, Felix Wezel, Christian Bolenz, Cagatay Gunes & Axel John. (2021) The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion. International Journal of Molecular Sciences 22:11, pages 5875.
Crossref
Zhenyu Xie, Xin Li, Yuzhen He, Song Wu, Shiyue Wang, Jianjian Sun, Yuchen He, Yu Lun, Shijie Xin & Jian Zhang. (2020) Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods. BMC Cancer 20:1.
Crossref
J. Zhang, L. Hou, D. Zhao, M. Pan, Z. Wang, H. Hu & J. He. (2017) Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells. Clinical and Translational Oncology 19:11, pages 1358-1374.
Crossref
Zhiqi Wang, Sai Li, Yu Cao, Xuefei Tian, Rong Zeng, Duan-Fang Liao & Deliang Cao. (2016) Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer. Oxidative Medicine and Cellular Longevity 2016, pages 1-15.
Crossref
MASASHI SHIIBA, KENGO SAITO, HITOMI YAMAGAMI, DAI NAKASHIMA, MORIHIRO HIGO, ATSUSHI KASAMATSU, YOSUKE SAKAMOTO, KATSUNORI OGAWARA, KATSUHIRO UZAWA, YUICHI TAKIGUCHI & HIDEKI TANZAWA. (2015) Interleukin-1 receptor antagonist (IL1RN) is associated with suppression of early carcinogenic events in human oral malignancies. International Journal of Oncology 46:5, pages 1978-1984.
Crossref
Arseniy E. Yuzhalin & Anton G. Kutikhin. 2015. Interleukins in Cancer Biology. Interleukins in Cancer Biology 17 61 .
Charles A. Dinarello. (2010) Why not treat human cancer with interleukin-1 blockade?. Cancer and Metastasis Reviews 29:2, pages 317-329.
Crossref
F Graziano, A Ruzzo, E Canestrari, F Loupakis, D Santini, E Rulli, B Humar, N Galluccio, R Bisonni, I Floriani, P Maltese, A Falcone, G Tonini, V Catalano, A Fontana, L Giustini, G Masi, B Vincenzi, P Alessandroni & M Magnani. (2008) Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. The Pharmacogenomics Journal 9:1, pages 78-84.
Crossref
Hubert Allgayer, Susanne Nicolaus & Stephan Schreiber. (2004) Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment. Cancer Detection and Prevention 28:3, pages 208-213.
Crossref
Mansoor Abdul & Naseema Hoosein. (2002) RELATIONSHIP OF THE INTERLEUKIN-1 SYSTEM WITH NEUROENDOCRINE AND EXOCRINE MARKERS IN HUMAN COLON CANCER CELL LINES. Cytokine 18:2, pages 86-91.
Crossref
H Shimamura, H Iwagaki, A Gouchi, Y Morimoto, N Ariki, M Funaki & N Tanaka. (2016) Autologous Serum Deprivation Restored IL-1 Receptor Antagonist Production by Peripheral Blood Mononuclear Cells in Patients with Gastric Cancer. Journal of International Medical Research 28:6, pages 277-287.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.